Related Experiment Video
Updated: Jul 1, 2025
06:28
A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
Published on: April 28, 2023
833
Acquired hypothalamic obesity: A clinical overview and update
Christian L Roth1,2, Shana E McCormack3,4
1Centre for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington, DC, USA.
Diabetes, Obesity & Metabolism
|March 7, 2024
Summary
Hypothalamic obesity (HO) is a rare disorder caused by hypothalamic damage, leading to severe obesity and hyperphagia. New treatments targeting energy homeostasis may offer future hope for managing this complex condition.
Area of Science:
- Neuroendocrinology
- Obesity Medicine
- Metabolic Disorders
Background:
- Hypothalamic obesity (HO) is a rare, complex endocrine-disorder characterized by impaired energy balance regulation.
- It often occurs with hypothalamic syndrome, affecting temperature, sleep, and energy homeostasis.
- HO involves disruptions in central pathways regulating appetite, metabolism, and hormonal signaling.
Purpose of the Study:
- To review the pathophysiology of hypothalamic obesity.
- To discuss the causes and clinical manifestations of HO.
- To explore potential future therapeutic strategies for HO.
Main Methods:
- Review of existing literature on hypothalamic obesity.
- Analysis of genetic and acquired forms of HO.
- Examination of the impact of hypothalamic damage on energy homeostasis.
Main Results:
- HO results from damage to hypothalamic pathways controlling energy intake and expenditure.
- Both genetic (e.g., monogenic obesity) and acquired causes (tumors, surgery, injury) lead to severe obesity.
- Key features include hyperphagia, leptin resistance, decreased energy expenditure, and rapid weight gain.
Conclusions:
- Current treatments for HO have limited long-term success.
- Understanding the distinct pathophysiology of acquired HO offers potential for novel therapeutic approaches.
- Future treatments may focus on restoring energy homeostasis in individuals with HO.
Related Concept Videos
01:24Obesity
498
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
498
01:37Hypothalamic-Pituitary Axis
60.0K
The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
60.0K
01:30Acute Pancreatitis II: Clinical Manifestations and Management
124
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
124
01:20Pathophysiology of Diabetes
928
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
928
01:22Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
01:22Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K